Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-09-06
1978-06-27
Rosen, Sam
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424317, A61K 31215, A61K 3119
Patent
active
040976033
ABSTRACT:
The present invention provides a method for prophylaxis of certain gastric inflammatory diseases by administration of gastric cytoprotective prostaglandins. Gastric cytoprotective prostaglandins refer to those prostaglandin-type compounds which are useful in reducing or preventing development of ulcers and other gastric lesions in the rat challenged by ingestion of ethanol, but which exhibit substantially no gastric antisecretory effects at the effective dosage for the present method.
REFERENCES:
patent: 3953495 (1976-04-01), Hayashi et al.
Armitage Robert A.
Rosen Sam
The Upjohn Company
LandOfFree
Gastric cytoprotection with non-antisecretory doses of prostagla does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gastric cytoprotection with non-antisecretory doses of prostagla, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gastric cytoprotection with non-antisecretory doses of prostagla will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2304681